Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01604031
Title Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

chronic lymphocytic leukemia

Therapies

Lenalidomide

Age Groups: adult
Covered Countries USA


No variant requirements are available.